Dr. Robert Huben Urology Roswell Park Cancer Institute Phone: (716) 845-3389 Email: hube@buffalo.edu

DESCRIPTION OF INTERESTS

Research interests involve the areas of general urologic oncology and in particular, the effect of chemotherapy and circadian administration of chemotherapeutic agents in the treatment of renal carcinoma.

PUBLICATIONS

Bahnson RR, Hanks GE, Huben RP, Kantoff P, Kozlowski JM, Kuettel M, Lange PH, Logothetis C, Pow-Sang JM, Roach M, Sandler H, Scardino PT, Taylor RJ, Urban DA, Walsh PC, Wilson TG; NCCN Practice Guidelines for Prostate Cancer.; Oncology (Huntingt); 2000 Nov; 14(11A); 111-119

Bielat KL, Halpern J, Simich JP, Huben RP, Ambrus JL; A morphological analysis of an in vitro model of cytotoxic antitumor activity.; Cancer Detect Prev; 12(1-6); 1-7

Fuchshuber, P., Jeffrey Lee, Robert Huben, Brian McGrath; Second Malignancy after Radiotherapy for Seminoma: Malignant Nerve Sheath Tumor Radiology; Malignant Nerve Sheath Tumor Radiology Oncology; 33(1); 59-61